3 Airway Clearance Techniques in Non Cystic Fibrosis Bronchiectasis

May 13, 2013 updated by: Beatriz Herrero, Hospital Clinic of Barcelona

A Comparative Study of Three Airway Clearance Techniques With Different Autonomy Degrees in Non Cystic Fibrosis Bronchiectasis: Randomized Cross-over Trial.

Study design: a randomized, crossover trial. Each patient performed three different airway clearance techniques (Autogenic drainage, slow expiratory with glottis opened in lateral posture [ELTGOL], temporary- positive expiratory pressure [T-PEP] with not similar autonomy degree in a randomized order. Each technique were applied in 3 sessions during one week at alternate days (Monday /Wednesday/Friday or Tuesday/Thursday/Saturday). The time spent in each bronchial session was 40 minutes. Seven days were the wash-out time period between the different techniques.

Study Overview

Study Type

Interventional

Enrollment (Actual)

31

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08029
        • Hospital Clínic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. - Non Cystic Fibrosis bronchiectasis diagnosed by High Resolution Computed Tomographic
  2. - Mean sputum production ≥ 15 ml /24h
  3. - Clinical stability in the last 6 weeks
  4. - Not carrying out regular chest physiotherapy
  5. - Forced expiratory volume in 1 second ≥ 30% pred. ; Forced Vital Capacity ≥ 45% pred. and peak expiratory flow >270 L/s

Exclusion Criteria:

  1. - Smoker or non-smoker form less than 2 years
  2. - Cystic fibrosis
  3. - Active tuberculosis or sarcoidosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Autogenic drainage
All patients performed all interventions in a randomized order. Each technique was applied in 3 non consecutively sessions during one week. The time spent during the session was 40 minutes
It was performed following J. Chevallier recommendations.In this trial it was considered a self-administrated technique because physiotherapist only gave oral advice in order to ensure a correct performance of the technique.
Active Comparator: Slow expiration with glottis opened in lateral posture
All patients performed all interventions in a randomized order.Each technique was applied in 3 non consecutively sessions during one week. The time spent during the session was 40 minutes
It was performed following Postiaux´s recommendations. In this trial the technique was considered active-assisted because the physiotherapy played a role important in their execution.
Other Names:
  • Slow expiratory with glotis opened in lateral position
Active Comparator: Temporary-Positive Expiratory Pressure
All patients performed all interventions in a randomized order. Each technique was applied in 3 non consecutively sessions during one week. The time spent during the session was 40 minutes
The diaphragmatic breathing was required for this technique whereas patients remain seated in front of the device with a nose clip. The inspiratory /expiratory ratio was 1:2.It was taken into account as a device-administrated technique for this trial.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight of sputum expectorated during each airway clearance therapy session
Time Frame: 40 minutes
Wet weight sputum production were recollected in one pre-weighted containers. It was measured in grams.
40 minutes
Weight of sputum expectorated 24 hours post each bronchial session
Time Frame: 24 hours
Wet weight sputum production were recollected in one pre-weighted containers. It was measured in grams.
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Saint George Respiratory Questionnaire (SGRQ)
Time Frame: Change from baseline at 5 weeks
Saint George Respiratory Questionnaire (SGRQ) is a self-completed health-related quality of life questionnaire.It was validated in bronchiectasis. It was administrated at the start and at the end of trial.
Change from baseline at 5 weeks
Leicester Cough Questionnaire (LCQ)
Time Frame: Changes from baseline arm to 1 week
Leicester Cough Questionnaire is a self-completed quality of life measure of the impact of cough severity. It was validated in bronchiectasis. It was administrated at the start and at the end of each technique.
Changes from baseline arm to 1 week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lung function measured by simple spirometry: forced expiratory volume in 1 second, Forced vital capacity, Forced expiratory flow 25-75
Time Frame: Change from baseline arm to 1 week
Change from baseline arm to 1 week
Likert test
Time Frame: Change from baseline arm to 1 week
It is a patient´s preferences measure. The questionnaire consists of a package of simple questions about the airway clearance techniques.
Change from baseline arm to 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Beatriz Herrero, Phy, Hospital Clinic of Barcelona
  • Study Director: Eva Polverino, Doctor, Hospital Clinic of Barcelona

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

August 1, 2012

Study Registration Dates

First Submitted

August 8, 2012

First Submitted That Met QC Criteria

May 13, 2013

First Posted (Estimate)

May 16, 2013

Study Record Updates

Last Update Posted (Estimate)

May 16, 2013

Last Update Submitted That Met QC Criteria

May 13, 2013

Last Verified

May 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bronchiectasis

Clinical Trials on Autogenic drainage

3
Subscribe